World PulseNow

Trending Stories

Loading trending stories...

Heatmap
About UsNews SourcesSubscribeMobileContact UsPrivacy Policy
© 2025 World Pulse Now
Search
Instantly search thousands of news articles from trusted sources.
Novo Nordisk to Cut 9,000 Jobs Amid Increased Competition
Financial MarketsJob CutsUpdated 19 hours ago

Novo Nordisk to Cut 9,000 Jobs Amid Increased Competition

Novo Nordisk, the Danish pharmaceutical company known for Ozempic and Wegovy, has announced plans to cut 9,000 jobs as part of a restructuring effort. This decision comes in response to intensified competition in the diabetes and weight-loss markets, leading to a lowered profit forecast and the company's second guidance downgrade in six weeks.

Related Articles
Ozempic Maker Novo Nordisk to Cut 9,000 Jobs
The New York Times19 hours ago
Ozempic Maker Novo Nordisk to Cut 9,000 Jobs
NegativeFinancial Markets
Novo Nordisk, the Danish drugmaker, announced it will cut 9,000 jobs to streamline operations amid increasing competition. This decision reflects the company's struggle to maintain its market lead.
Editor’s Note: This job cut is significant as it highlights the challenges faced by pharmaceutical companies in a competitive landscape. It raises concerns about job security and the future direction of the company.
Read full article
via The New York Times
Wegovy maker Novo Nordisk to cut 9,000 jobs amid increased competition
The Guardian20 hours ago
Wegovy maker Novo Nordisk to cut 9,000 jobs amid increased competition
NegativeFinancial Markets
Novo Nordisk, the Danish manufacturer of Wegovy and Ozempic, is cutting 9,000 jobs due to increased competition from Eli Lilly and a reduced profit forecast.
Editor’s Note: This job cut is significant as it reflects the intense competition in the weight-loss and diabetes drug market, particularly from US rival Eli Lilly. The decision may impact many employees and the local economy in Denmark.
Read full article
via The Guardian
Ozempic Maker Novo Nordisk to Cut 9,000 Jobs
Wall Street Journal21 hours ago
Ozempic Maker Novo Nordisk to Cut 9,000 Jobs
NegativeFinancial Markets
Novo Nordisk, the maker of Ozempic, is set to cut 9,000 jobs as part of a restructuring plan. This marks the second downgrade in guidance within six weeks.
Editor’s Note: This job cut is significant as it reflects the company's challenges and the impact of restructuring on employees. It raises concerns about the future of the workforce and the company's direction.
Read full article
via Wall Street Journal
Ozempic Maker Novo Nordisk to Cut 9,000 Jobs
Wall Street Journal21 hours ago
Ozempic Maker Novo Nordisk to Cut 9,000 Jobs
NegativeFinancial Markets
Novo Nordisk, the maker of Ozempic, plans to cut 9,000 jobs as part of a restructuring plan. This marks the second downgrade of its guidance in six weeks.
Editor’s Note: This job cut is significant as it reflects the company's struggles and the impact of market conditions on its operations. It raises concerns about the future of employees and the company's overall health.
Read full article
via Wall Street Journal
Ozempic Producer Novo Nordisk Announces 9,000 Job Cuts Amidst Increased Competition
Finance Monthlya day ago
Ozempic Producer Novo Nordisk Announces 9,000 Job Cuts Amidst Increased Competition
NegativeFinancial Markets
Novo Nordisk, the producer of Ozempic, has announced plans to cut 9,000 jobs due to increased competition in the diabetes and weight-loss market.
Editor’s Note: This job cut is significant as it reflects the challenges faced by pharmaceutical companies in a competitive landscape. The decision may impact many employees and the overall market for diabetes treatments.
Read full article
via Finance Monthly
Novo to Cut Workforce by 11%, CEO Lowers Profit Forecast
Bloomberga day ago
Novo to Cut Workforce by 11%, CEO Lowers Profit Forecast
NegativeFinancial Markets
Novo Nordisk plans to cut 9,000 jobs worldwide and has lowered its profit forecast for the third time this year. The company aims to save 8 billion kroner by 2026.
Editor’s Note: This workforce reduction highlights the challenges faced by Novo Nordisk as it adjusts to market conditions. The cuts may impact employees and the company's operations, raising concerns about the future of its popular products.
Read full article
via Bloomberg
Ozempic-maker Novo Nordisk to cut 9,000 jobs
BBC Newsa day ago
Ozempic-maker Novo Nordisk to cut 9,000 jobs
NegativeFinancial Markets
Novo Nordisk, the maker of Ozempic and Wegovy, plans to cut 9,000 jobs due to rising competition from generic drugs.
Read full article
via BBC News

Why World Pulse Now?

Global Coverage

All major sources, one page

Emotional Lens

Feel the mood behind headlines

Trending Stories

Know what’s trending, globally

Read Less, Know More

Get summaries. Save time

Multi-Language

Switch languages to read your way

Save for Later

Your stories, stored for later

Stay informed, save time
Learn more

Live Stats

Our system have analyzed 5,177 articles worldwide

That's roughly 215 articles per hour

569 trending stories shaping headlines worldwide

From breaking news to viral moments

AI-driven monitoring of 200 trusted sources, nonstop

From major news outlets to specialized publications

The latest update landed just 33 minutes ago

We never sleep, so you're always informed

Live data processing
How it works

Mobile App

Available on iOS & Android

The mobile app adds more ways to stay informed — including offline reading, voice-enabled summaries, and personalized trend alerts.

Get it on Google PlayDownload on the App Store
Available now on iOS and Android

1-Minute Daily Briefing

Stay sharp in 60 seconds. Get concise summaries of today’s biggest stories — markets, tech, sports, and more

By subscribing, you agree to our Privacy Policy